12 Well being Care Shares Shifting In Tuesday’s After-Market Session – Adaptimmune Therapeutics (NASDAQ:ADAP), AN2 Therapeutics (NASDAQ:ANTX)

Gainers

• Cyclerion Therapeutics CYCN inventory rose 47.4% to $4.45 throughout Tuesday’s after-market session. The market worth of their excellent shares is at $9.7 million.
• Utilized Therapeutics APLT shares rose 11.21% to $0.5. The market worth of their excellent shares is at $68.5 million.
• Rallybio RLYB shares rose 6.29% to $0.62. The market worth of their excellent shares is at $25.4 million.
• SAB Biotherapeutics SABS inventory elevated by 6.19% to $2.4. The corporate’s market cap stands at $23.0 million.
• AN2 Therapeutics ANTX shares moved upwards by 5.79% to $1.35. The market worth of their excellent shares is at $36.6 million.
• Adaptimmune Therapeutics ADAP inventory moved upwards by 5.26% to $0.16. The market worth of their excellent shares is at $44.3 million.

Losers

• Aytu BioPharma AYTU inventory decreased by 13.3% to $2.22 throughout Tuesday’s after-market session. The corporate’s market cap stands at $22.3 million. As per the information, the This autumn earnings report got here out at this time.
• Incannex Healthcare IXHL inventory declined by 10.66% to $0.6. The corporate’s market cap stands at $38.5 million.
• Soligenix SNGX inventory fell 5.65% to $1.84. The market worth of their excellent shares is at $7.6 million.
• Apimeds Prescription drugs APUS inventory fell 4.69% to $1.83. The corporate’s market cap stands at $24.6 million.
• Basel Medical Group BMGL shares declined by 4.22% to $1.82. The corporate’s market cap stands at $33.4 million.
• Test-Cap CHEK shares declined by 3.75% to $2.16. The corporate’s market cap stands at $14.3 million.
  See Additionally: www.benzinga.com/cash/best-healthcare-stocks/

This text was generated by Benzinga’s automated content material engine and reviewed by an editor.